{"id":"https://openalex.org/W2001192272","doi":"https://doi.org/10.2165/11589470-000000000-00000","title":"Changes in Utilization and Costs for Patients with Rheumatoid Arthritis, 1997 to 2006","display_name":"Changes in Utilization and Costs for Patients with Rheumatoid Arthritis, 1997 to 2006","publication_year":2012,"publication_date":"2012-03-04","ids":{"openalex":"https://openalex.org/W2001192272","doi":"https://doi.org/10.2165/11589470-000000000-00000","mag":"2001192272","pmid":"https://pubmed.ncbi.nlm.nih.gov/22379953"},"language":"en","primary_location":{"id":"doi:10.2165/11589470-000000000-00000","doi":"https://doi.org/10.2165/11589470-000000000-00000","is_oa":false,"landing_page_url":"https://doi.org/10.2165/11589470-000000000-00000","pdf_url":null,"source":{"id":"https://openalex.org/S43019230","display_name":"PharmacoEconomics","issn_l":"1170-7690","issn":["1170-7690","1179-2027"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111579901","display_name":"Howard G. Birnbaum","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79463011","display_name":"Analysis Group (United States)","ror":"https://ror.org/044jp1563","country_code":"US","type":"company","lineage":["https://openalex.org/I79463011"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Howard G. Birnbaum","raw_affiliation_strings":["Analysis Group Inc., Boston, MA, USA. hbirnbaum@analysisgroup.com","Analysis Group Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analysis Group Inc., Boston, MA, USA. hbirnbaum@analysisgroup.com","institution_ids":["https://openalex.org/I79463011"]},{"raw_affiliation_string":"Analysis Group Inc","institution_ids":["https://openalex.org/I79463011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111619334","display_name":"Crystal T. Pike","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79463011","display_name":"Analysis Group (United States)","ror":"https://ror.org/044jp1563","country_code":"US","type":"company","lineage":["https://openalex.org/I79463011"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Crystal Pike","raw_affiliation_strings":["Analysis Group, Inc., 111 Huntington Avenue, 10th floor, Boston, MA, 02199, USA","Analysis Group Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analysis Group, Inc., 111 Huntington Avenue, 10th floor, Boston, MA, 02199, USA","institution_ids":["https://openalex.org/I79463011"]},{"raw_affiliation_string":"Analysis Group Inc","institution_ids":["https://openalex.org/I79463011"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ritesh Banerjee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79463011","display_name":"Analysis Group (United States)","ror":"https://ror.org/044jp1563","country_code":"US","type":"company","lineage":["https://openalex.org/I79463011"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ritesh Banerjee","raw_affiliation_strings":["Analysis Group, Inc., 111 Huntington Avenue, 10th floor, Boston, MA, 02199, USA","Analysis Group Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analysis Group, Inc., 111 Huntington Avenue, 10th floor, Boston, MA, 02199, USA","institution_ids":["https://openalex.org/I79463011"]},{"raw_affiliation_string":"Analysis Group Inc","institution_ids":["https://openalex.org/I79463011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109910422","display_name":"Tracy Waldman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79463011","display_name":"Analysis Group (United States)","ror":"https://ror.org/044jp1563","country_code":"US","type":"company","lineage":["https://openalex.org/I79463011"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tracy Waldman","raw_affiliation_strings":["Analysis Group, Inc., 111 Huntington Avenue, 10th floor, Boston, MA, 02199, USA","Analysis Group Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analysis Group, Inc., 111 Huntington Avenue, 10th floor, Boston, MA, 02199, USA","institution_ids":["https://openalex.org/I79463011"]},{"raw_affiliation_string":"Analysis Group Inc","institution_ids":["https://openalex.org/I79463011"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109962019","display_name":"Mary A. Cifaldi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019813218","display_name":"Abbott (United Kingdom)","ror":"https://ror.org/03wnay029","country_code":"GB","type":"company","lineage":["https://openalex.org/I3019813218","https://openalex.org/I4210088555"]},{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Mary Cifaldi","raw_affiliation_strings":["Global Health Economics and Outcomes Research, Abbott Laboratories, Abbott Park, IL, USA","Global Health Economics and Outcomes Research, Abbott Laboratories"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Health Economics and Outcomes Research, Abbott Laboratories, Abbott Park, IL, USA","institution_ids":["https://openalex.org/I4210088555"]},{"raw_affiliation_string":"Global Health Economics and Outcomes Research, Abbott Laboratories","institution_ids":["https://openalex.org/I3019813218","https://openalex.org/I4210088555"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5111579901"],"corresponding_institution_ids":["https://openalex.org/I79463011"],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":null,"fwci":1.2003,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.77681839,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"30","issue":"4","first_page":"323","last_page":"336"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10084","display_name":"Musculoskeletal pain and rehabilitation","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3612","display_name":"Physical Therapy, Sports Therapy and Rehabilitation"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":1.0},{"id":"https://openalex.org/keywords/health-care-utilization","display_name":"health care utilization","score":0.9610000252723694},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.9869999885559082},{"id":"https://openalex.org/keywords/work-loss-costs","display_name":"work loss costs","score":0.8339999914169312},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.8510000109672546},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.6859999895095825},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.7020000219345093},{"id":"https://openalex.org/keywords/emergency-department-visits","display_name":"emergency department visits","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-costs","display_name":"drug costs","score":0.8379999995231628},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.6610000133514404},{"id":"https://openalex.org/keywords/employed-patients","display_name":"employed patients","score":0.6359999775886536},{"id":"https://openalex.org/keywords/cost-reduction","display_name":"cost reduction","score":0.3409999907016754}],"concepts":[{"id":"https://openalex.org/C524218345","wikidata":"https://www.wikidata.org/wiki/Q31218","display_name":"Health economics","level":3,"score":0.8597110509872437},{"id":"https://openalex.org/C2778091340","wikidata":"https://www.wikidata.org/wiki/Q15749950","display_name":"Quality of Life Research","level":3,"score":0.7864716649055481},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.7720611095428467},{"id":"https://openalex.org/C137992405","wikidata":"https://www.wikidata.org/wiki/Q1137608","display_name":"Health administration","level":3,"score":0.6477477550506592},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6328948140144348},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.5774909257888794},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.46901553869247437},{"id":"https://openalex.org/C2776738588","wikidata":"https://www.wikidata.org/wiki/Q1567856","display_name":"Pharmacoeconomics","level":2,"score":0.4627890884876251},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.33705905079841614},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2978687286376953},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.1001826822757721}],"mesh":[{"descriptor_ui":"D000041","descriptor_name":"Absenteeism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D004636","descriptor_name":"Emergency Service, Hospital","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D004636","descriptor_name":"Emergency Service, Hospital","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D004636","descriptor_name":"Emergency Service, Hospital","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D004651","descriptor_name":"Employment","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D004651","descriptor_name":"Employment","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D006296","descriptor_name":"Health Services","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D006296","descriptor_name":"Health Services","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D006296","descriptor_name":"Health Services","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016022","descriptor_name":"Case-Control Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017048","descriptor_name":"Health Care Costs","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D017281","descriptor_name":"Cost of Illness","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.2165/11589470-000000000-00000","doi":"https://doi.org/10.2165/11589470-000000000-00000","is_oa":false,"landing_page_url":"https://doi.org/10.2165/11589470-000000000-00000","pdf_url":null,"source":{"id":"https://openalex.org/S43019230","display_name":"PharmacoEconomics","issn_l":"1170-7690","issn":["1170-7690","1179-2027"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"journal-article"},{"id":"pmid:22379953","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22379953","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"Journal Article"},{"id":"pmh:oai:RePEc:spr:pharme:v:30:y:2012:i:4:p:323-336","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10.2165/11589470-000000000-00000","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"},{"id":"pmh:oai:RePEc:wkh:phecon:v:30:y:2012:i:4:p:323-336","doi":null,"is_oa":false,"landing_page_url":"http://PharmacoEconomics.adisonline.com/pt/re/pec/fulltext.00019053-201230040-00004.htm","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9789000153541565}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306085","display_name":"U.S. Department of Health and Human Services","ror":"https://ror.org/033jnv181"},{"id":"https://openalex.org/F4320306493","display_name":"Abbott Laboratories","ror":"https://ror.org/0052svj16"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W54366243","https://openalex.org/W132980945","https://openalex.org/W183402285","https://openalex.org/W1487018400","https://openalex.org/W1522863980","https://openalex.org/W1556890549","https://openalex.org/W1833163659","https://openalex.org/W1884756792","https://openalex.org/W1979364075","https://openalex.org/W1985763670","https://openalex.org/W1996389186","https://openalex.org/W2000445173","https://openalex.org/W2009277654","https://openalex.org/W2009688407","https://openalex.org/W2011966376","https://openalex.org/W2013471188","https://openalex.org/W2018270810","https://openalex.org/W2021832018","https://openalex.org/W2029049283","https://openalex.org/W2031501202","https://openalex.org/W2058064986","https://openalex.org/W2076834039","https://openalex.org/W2090929542","https://openalex.org/W2091732273","https://openalex.org/W2105422073","https://openalex.org/W2116927211","https://openalex.org/W2134514260","https://openalex.org/W2136994981","https://openalex.org/W2144160860","https://openalex.org/W2144368920","https://openalex.org/W2149860264","https://openalex.org/W2172111517","https://openalex.org/W2217934711","https://openalex.org/W2312997470","https://openalex.org/W2319957449","https://openalex.org/W2340084730"],"related_works":["https://openalex.org/W2332520900","https://openalex.org/W2095590272","https://openalex.org/W2884587362","https://openalex.org/W3011532946","https://openalex.org/W2982092710","https://openalex.org/W2795663759","https://openalex.org/W2320128840","https://openalex.org/W6958290739","https://openalex.org/W7165489016","https://openalex.org/W2899641813"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}